Background and Study Aims: The aim of the present study was to analyze the risk factors
associated with complications of endoscopic sphincterotomy (ES).
Patients and Methods: In all consecutive endoscopic sphincterotomies carried out between
September 1994 and December 1996, the possible risk factors (12 patient-related factors
and 12 procedure-related ones), as well as the concomitant medical treatment, indications,
techniques, and success of endoscopic sphincterotomy were evaluated prospectively.
Risk factors were analyzed on an exploratory basis using univariate methods. “Potential
risk factors” (univariate, P < 0.1) underwent multivariate analysis to determine independent
“risk factors” (multivariate, P < 0.05). In addition, the complication rate was calculated
according to the number of potential risk factors present.
Results: A total of 438 patients who underwent ES were analyzed. Complications occurred
in 7.5 % (n = 33; acute pancreatitis 4.3 %, hemorrhage 2.3 %, cholangitis 0.9 %, technical
0.2 %). Statistical analysis of the complications identified three independent risk
factors (coagulopathy, patient age (≤ 60 years, pancreas divisum), and one protective
factor (pancreatic duct obstruction). The frequency of acute pancreatitis was increased
by two independent risk factors (pancreas divisum, ES frequency < 40 procedures/year)
and was reduced if low-dose anticoagulation (unfractionated heparin or low molecular
weight heparin) was administered (0.9 %, one of 115 vs. 5.8 %, 18 of 313; P < 0.05).
The effect of anticoagulation was not confounded by the presence or absence of other
potential risk factors for acute pancreatitis. Neither the risk nor the severity of
hemorrhage were increased by low-dose anticoagulation. Due to the low number of events,
only potential risk factors for hemorrhage were identified (coagulopathy, intensive-care
treatment). The overall complication rate and the incidence of pancreatitis and hemorrhage
increased significantly depending on the number of simultaneous potential risk factors
present (P < 0.0001).
Conclusions: Patients at risk for complications after endoscopic sphincterotomy can
be identified by risk factor analysis. These data suggest the hypothesis that low-dose
anticoagulation prior to endoscopic sphincterotomy reduces the risk of acute pancreatitis
after sphincterotomy.
References
1
Cotton PB, Lehmann GA, Vennes J, et al.
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
Gastrointest Endosc.
1991;
37
338-393
2
Freeman ML, Nelson DB, Sherman S, et al.
Complications of endoscopic biliary sphincterotomy.
N Engl J Med.
1996;
335
909-918
3
Ell C, Rabenstein T, Ruppert T, et al.
20 Jahre endoskopische Papillotomie - Analyse der Erlanger Erfahrungen bei 2752 Patienten.
Dtsch Med Wochenschr.
1995;
120
163-167
4
Rabenstein T, Schneider HT, Hahn EG, et al.
25 years of endoscopic sphincterotomy in Erlangen: assessment of experience in the
treatment of 3498 patients.
Endoscopy.
1998;
30 (Suppl 2)
201
5
Huibregtse K.
Complications of endoscopic sphincterotomy and their prevention.
N Engl J Med.
1996;
335
961-963
6
Classen M, Demling L.
Endoskopische Sphinkterotomie der Papilla Vateri und Steinextraktion aus dem Ductus
choledochus.
Dtsch Med Wochenschr.
1974;
99
496-497
7
Kawai KY, Ahasaha K, Murakami M.
Endoscopic sphincterotomy of the papilla of Vater.
Gastrointest Endosc.
1974;
20
148-150
8
Riemann JF, Seuberth K, Demling L.
Mechanical lithotripsy of common bile duct stones.
Gastrointest Endosc.
1984;
30
140-141
9
Rabenstein T, Ruppert T, Schneider HT, Hahn EG, Ell C.
Benefits and risks of needle-knife papillotomy.
Gastrointest Endosc.
1997;
46
207-211
10
Rabenstein T, Schneider HT, Nicklas M, Hahn EG, Ell C.
Significance of the endoscopist on success and complications of EST: comparison of
experienced and learning endoscopists.
Gastrointest Endosc.
1999;
50
628-636
11
Ell C, Rabenstein T, Schneider HT, et al.
Safety and efficacy of pancreatic sphincterotomy in chronic pancreatitis.
Gastrointest Endosc.
1998;
48
244-249
12 Classen M.
Endoscopic papillotomy. In: Sivak MV (ed). Gastroenterologic endoscopy. Philadelphia; Saunders, 1987: 631-653
13
Huibregtse K, Katon RM, Tytgat GNJ.
Precut papillotomy via fine needle-knife papillotome: a safe and effective technique.
Gastrointest Endosc.
1986;
32
403-405
14 Armitage P, Berry G.
Statistical methods in medical research. 3rd ed . Oxford; Blackwell Science 1994: 311
15 Hochberg Y, Tamhane AC (eds).
Multiple comparison procedures. New York; Wiley, 1987
16
Concato J, Feinstein AR, Holford TR.
The risk of determining risk with multivariate models.
Ann Intern Med.
1993;
118
201-210
17 Hosmer DW Jr, Lemeshow S (eds).
Applied logistic regression. New York; Wiley, 1989
18
Boender J, Nix GAJJ, de Ridder MAJ, et al.
Endoscopic papillotomy for common bile duct stones: factors influencing the complication
rate.
Endoscopy.
1994;
26
209-216
19
Lambert ME, Betts CD, Hill J, et al.
Endoscopic sphincterotomy: the whole truth.
Br J Surg.
1991;
78
473-476
20
Sherman S, Ruffolo TA, Hawes RH, Lehman GA.
Complications of endoscopic sphincterotomy: a prospective series with emphasis on
the increased risk associated with sphincter of Oddi dysfunction and nondilated bile
ducts.
Gastroenterology.
1991;
101
1068-1075
21
Vaira D, Ainley C, Williams S, et al.
Endoscopic sphincterotomy in 1000 consecutive patients.
Lancet.
1989;
8660
431-434
22
Wojtun S, Gil J, Gietka W, Gil M.
Endoscopic sphincterotomy for choledocholithiasis: a prospective single-center study
on the short-term and long-term treatment results in 483 patients.
Endoscopy.
1997;
29
258-265
23
Jowell PS, Baillie J, Branch MS, et al.
Quantitative assessment of procedural competence: a prospective study of training
in endoscopic retrograde cholangiopancreatography.
Ann Intern Med.
1996;
125
983-989
24
Jowell PS, Branch MS, Afforti J, et al.
At least 180 ERCPs are needed to attain competence in diagnostic and therapeutic ERCP
[abstract].
Gastrointest Endosc.
1996;
43
314
25
Freeman ML.
Complications of endoscopic biliary sphincterotomy: a review.
Endoscopy.
1997;
29
228-297
26
Schneider HT, May A, Benninger J, et al.
Piezoelectric shock wave lithotripsy of pancreatic duct stones.
Am J Gastroenterol.
1994;
89
2042-2048
27
Cremer M, Devière J, Delhaye M, et al.
Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six
patients.
Endoscopy.
1991;
23
171-176
28
Kozarek RA, Ball TJ, Patterson DJ, et al.
Endoscopic pancreatic duct sphincterotomy: indications, technique and analysis of
results.
Gastrointest Endosc.
1994;
40
592-598
29
Smits ME, Rauw EAS, Tytgat GJ, Huibregtse K.
Endoscopic treatment of pancreatic stones in patients with chronic pancreatitis.
Gastrointest Endosc.
1996;
43
556-560
30
Dumonceau JM, Devière J, Le Moine O, et al.
Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones:
long-term results.
Gastrointest Endosc.
1996;
43
547-555
31
Slot WB, Schoeman MN, Disario JA, et al.
Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy
and complications.
Endoscopy.
1996;
28
334-339
32
Binmoeller KF, Seifert H, Gerke H, et al.
Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve selective
bile duct cannulation.
Gastrointest Endosc.
1996;
44
689-695
33
Dowset JF, Polydorou AA, Vaira D, et al.
Needle-knife papillotomy: how safe and how effective?.
Gut.
1990;
31
905-908
34
Foutch PG.
A prospective assessment of results for needle-knife papillotomy and standard endoscopic
sphincterotomy.
Gastrointest Endosc.
1995;
41
25-32
35
Baillie J.
Needle-knife papillotomy revisited.
Gastrointest Endosc.
1997;
46
282-284
36
Siegel HJ.
Precut papillotomy: a method to improve success of ERCP and papillotomy.
Endoscopy.
1980;
20
130-133
37
Siegel HJ, Ben-Zvi JS, Pullano W.
The needle-knife: a valuable tool in diagnostic and therapeutic ERCP.
Gastrointest Endosc.
1989;
35
499-503
38
Vandervoort J, Carr-Locke DL.
Needle-knife access papillotomy: an unfairly maligned technique?.
Endoscopy.
1996;
28
365-366
39
Tham TCK, Vandervoort L, Wong RCK, et al.
Therapeutic ERCP in outpatients.
Gastrointest Endosc.
1997;
45
225-230
40
Vandervoort J, Tham TCK, Wong RCK, et al.
Prospective analysis of risk factors for pancreatitis after diagnostic and therapeutic
ERCP [abstract].
Gastrointest Endosc.
1996;
43
440
41
Vandervoort J, Tham TCK, Wong RCK, et al.
Prospective study of post-ERCP complications following diagnostic and therapeutic
ERCP [abstract].
Gastrointest Endosc.
1996;
43
441
42
Booth FV, Doerr RJ, Khalafi RS, et al.
Surgical management of complications of endoscopic sphincterotomy with precut papillotomy.
Am J Surg.
1990;
159
132-135
43
Tweedle DEF, Martin FF.
Needle-knife papillotomy for endoscopic sphincterotomy and cholangiography.
Gastrointest Endosc.
1991;
37
518-521
44
Shakoor T, Geenen JE.
Precut papillotomy.
Gastrointest Endosc.
1992;
38
623-627
45
Cotton PB.
Precut papillotomy: a risky technique for experts only.
Gastrointest Endosc.
1989;
35
578-579
46
Chen YK, Foliente RL, Santoro MJ, et al.
Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated
bile ducts and sphincter of Oddi dysfunction.
Am J Gastroenterol.
1994;
89
327-333
47
Sherman S, Lehmann GA.
ERCP and endoscopic sphincterotomy-induced pancreatitis.
Pancreas.
1991;
6
350-67
48
Geenen JE, Hogan WJ, Dodds WJ, et al.
Long-term results of endoscopic sphincterotomy for treating patients with sphincter
of Oddi dysfunction.
Gastroenterology.
1989;
92
1401-1405
49
Tittobello A.
Diagnosis and prevention of post-EST pancreatitis.
Endoscopy.
1997;
29
285-287
50
Toulon P, Chadeuf G, Bouillot JL, et al.
Involvement of heparin cofactor II in chymotrypsin neutralization and in pancreatic
proteinase-antiproteinase interaction during acute pancreatitis in man.
Eur J Clin Invest.
1991;
21
303-309
51
Kosidlo S, Gabryelewicz A, Prokopowicz J, Prokopowicz K.
Pancreatic proteolytic and inhibitory activity during acute experimental pancreatitis
in rats with reference to heparin treatment.
Mater Med Pol.
1986;
18
136-143
52
Gabryelewicz A, Kosidlo S, Prokopowicz J, Prokopowicz K.
Does heparin modify protease-antiprotease balance in acute experimental pancreatitis
in rats?.
Hepatogastroenterology.
1986;
33
79-92
53
Bleeker WK, Agterberg J, Rigter G, et al.
Protective effect of antithrombin III in acute experimental pancreatitis in rats.
Dig Dis Sci.
1992;
37
280-285
54
Suda K.
Histopathological study on fat necrosis with comparison between agonal stage and acute
pancreatitis.
Rinsho Byori.
1991;
39
977-980
M.D. T. Rabenstein
Medizinische Klinik I mit Poliklinik Universität Erlangen-Nürnberg
Krankenhausstrasse 12
91054 Erlangen, Germany
Phone: +49-9131-8536909
Email: Thomas.Rabenstein@med1.med.uni-erlangen.de